Controlling the Polymorphism of Active Pharmaceutical Ingredients with Two-Dimensional Templates by Cox, Jason R
Worcester Polytechnic Institute
Digital WPI
Masters Theses (All Theses, All Years) Electronic Theses and Dissertations
2009-04-27
Controlling the Polymorphism of Active
Pharmaceutical Ingredients with Two-Dimensional
Templates
Jason R. Cox
Worcester Polytechnic Institute
Follow this and additional works at: https://digitalcommons.wpi.edu/etd-theses
This thesis is brought to you for free and open access by Digital WPI. It has been accepted for inclusion in Masters Theses (All Theses, All Years) by an
authorized administrator of Digital WPI. For more information, please contact wpi-etd@wpi.edu.
Repository Citation
Cox, Jason R., "Controlling the Polymorphism of Active Pharmaceutical Ingredients with Two-Dimensional Templates" (2009). Masters
Theses (All Theses, All Years). 362.
https://digitalcommons.wpi.edu/etd-theses/362
  
CONTROLLING THE POLYMORPHISM OF ACTIVE PHARMACEUTICAL 
INGREDIENTS WITH TWO-DIMENSIONAL TEMPLATES 
 
 
 
 
 
M.S. THESIS  
 
 
SUBMITTED BY 
 
 
JASON R. COX 
 
DEPARTMENT OF CHEMISTRY AND BIOCHEMISTRY 
WORCESTER POLYTECHNIC INSTITUTE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 
 
TABLE OF CONTENTS 
 
1 Introduction ...................................................................................................................... 2 
1.1 Objectives ................................................................................................................. 2 
1.2 Definitions................................................................................................................. 2 
1.3 Polymorphism and Structure-Property Relations ..................................................... 3 
1.4 Impact of Polymorphism on Drug Development and Marketing ............................. 3 
1.5 Previous Approaches to Controlling Polymorphism ................................................ 4 
1.6 Rationale for Current Work ...................................................................................... 5 
2 Selective Nucleation - Theophylline ................................................................................ 6 
2.1 Background ............................................................................................................... 6 
2.2 Results ....................................................................................................................... 7 
2.3 Preparation of SAMs............................................................................................... 11 
2.4 Characterization of SAMs....................................................................................... 12 
2.5 Crystal Growth on SAMs........................................................................................ 14 
2.6 Summary ................................................................................................................. 18 
3 Suppressed Nucleation - Indomethacin ......................................................................... 19 
3.1 Background ............................................................................................................. 19 
3.2 Results ..................................................................................................................... 19 
3.3 Preparation of Substrates ........................................................................................ 24 
3.4 Characterization of Substrates ................................................................................ 25 
3.5 Crystal Growth ........................................................................................................ 26 
3.6 Polymorph Characterization ................................................................................... 27 
3.7 Summary ................................................................................................................. 30 
4 Microwave Assisted Polymorph Selection .................................................................... 32 
4.1 Background ............................................................................................................. 32 
4.2 Initial Results .......................................................................................................... 32 
4.3 API Crystallization.................................................................................................. 32 
4.4 Selective Heating and Micro-Emulsions ................................................................ 33 
5 References ...................................................................................................................... 35 
 
 
 
2 
1 INTRODUCTION 
 
1.1 Objectives 
The aim of this work is to examine the effect of interfaces on the crystallization of 
compounds that exhibit polymorphism. Specifically, we are interested in monolayers 
derived from thiol-based surfactants bearing functional groups that may promote face 
selective growth through epitaxy. The ultimate objective of this work is to get a better 
understanding of interfacial interactions and molecular recognition during crystal growth 
in order to pave the way toward the development of new tools to control the outcome of 
crystal growth. 
1.2 Definitions 
The term polymorphism, in relation to solid state chemistry, was first coined by 
Mitscherlich in 1822.
1
 He recognized that inorganic compounds could adopt more than 
one arrangement of ions in the solid state.  In 1965, a more encompassing definition was 
developed by McCrone.
2
 He defined polymorphism as, ‘a solid crystalline phase of a 
given compound resulting from the possibility of at least two different arrangements of 
that compound in the solid state’.  This definition also includes conformational 
polymorphism which is the ability of a molecule to adopt different conformations in 
different solid forms. In addition, pure compounds can form hydrates or solvates wherein 
water or solvent molecules are present periodically (and usually in a stoichiometric ratio) 
throughout the crystal lattice. We refer to these multicomponent solids as hydrates and 
solvates.
3 
 
 
 
 
Figure 1. Schematic depiction of different types of polymorphism. (a-b) polymorphs, 
(c) hydrate or solvate, and (d) conformational polymorph of (a). 
 
conformationally flexible molecule
solvent or water molecule
a b c
d
 
3 
1.3 Polymorphism and Structure-Property Relations 
One encounters the structure-property relationships of different polymorphs on a daily 
basis. A familiar example is given by the two allotropes of carbon – graphite and 
diamond. Both materials are exclusively made of carbon yet they exhibit distinct physical 
properties. Diamond is the hardest material known on earth and is coveted for its clarity 
and beauty as a gemstone, whereas graphite is typically used in pencils and as a lubricant. 
 
 
 
Figure 2. Crystal structures of two polymorphs of acetaminophen. (Gray = C, 
Red = O, Blue = N, Yellow = H) (a) Crystal structure of acetaminophen form I. 
View along a-axis. (b) Crystal structure of acetaminophen form II. View along b-
axis. Note the slip plane between the molecular sheets in form II.
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In the case of molecular crystals, the spatial organization of the molecules is determined 
by noncovalent interactions such as hydrogen bonds. These interactions act as 
intermolecular glue, and due to their directionality and strength, determine the orientation 
of molecules in the solid state. In the case of polymorphs, noncovalent bonding motifs are 
different and generate unique packing arrangements (Figure 2). The results of unique 
packing arrangements are manifested in the physical properties and characteristics of the 
different modifications. Polymorphs exhibit differences in density, melting point, thermal 
conductivity, enthalpy, and solubility to name a few.
5
 The pharmaceutical industry is 
particularly concerned with polymorphism because polymorphs of active pharmaceutical 
ingredients (APIs) exhibit differences in bioavailability, shelf-life and communition.
6
 
These differences may make one polymorph more suitable than another as a drug 
candidate, they also emphasize the importance of polymorph screening in drug 
development. 
1.4 Impact of Polymorphism on Drug Development and Marketing 
In recent years, the topic of polymorphism has been involved in a number of high profile 
cases. Showcasing this situation is ritonavair; a protease inhibitor drug manufactured by 
Abbott Laboratories under the trade name Norvir®. After approximately 18 months on 
the market, a new polymorph of the drug had begun to dominate the production line. This 
new modification is more stable than the original marketed form and exhibits decreased 
dissolution rates as well as inferior bioavailability. Abbott was forced to recall the drug 
from the market and subsequently developed a liquid suspension of the drug after an 
intense year long research effort.
7
 This event is symbolic of the importance of 
determining the most stable form of a drug early in drug development processes. 
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Polymorphism has also become a topic of concern in patent litigation. As stated earlier, 
polymorphs of the same pure substance each possess discrete packing motifs in the solid 
state. In patent law, a polymorph may be considered worthy of patent protection if the 
new form is ‘unobvious’. A patent litigation involving Glaxo Smithkline typifies the 
situation. Ranitidine hydrochloride, the active ingredient in the popular heartburn 
medication Zantac®, was the center of debate in the late 1980’s and early 1990’s. Glaxo 
Smithkline (GSK) already possessed the production rights to the drug when they 
serendipitously discovered a second form of the compound, which they patented for its 
improved drying and filtration characteristics. Novapharm Ltd, a generic pharmaceutical 
company, sought to prepare the old form by following the procedures outlined in the 
original patent but obtained only the new form. Novapharm argued that the ranitidine 
hydrochloride present in Zantac® is, and also has been, the new form and that the 
original patent was incorrect. A lengthy legal battle ensued, and at the end GSK won the 
case and protected their patents.
8 
 
The above scenarios emphasize the need to screen for polymorphs early in drug 
development. In Abbott’s case, early detection of the more stable form may have 
prevented the fallout resulting from the late stage phase transformation. The situation 
involving GSK and Novapharm Ltd illustrates how subtle differences in drug preparation 
can have a profound impact on the polymorph obtained.  
1.5 Previous Approaches to Controlling Polymorphism 
Selective growth of polymorphs, for the most part, has been a trial and error process. 
Typically, screens are carried out by varying physical conditions such as temperature, 
pressure, solvents, and initial saturation levels. Recently, this approach has been adapted 
for use in a high-throughput environment.
9
 This trial and error approach is limited in that 
it is empirical and does not control or influence nucleation in a planned manner.  
 
Nucleation, broadly defined, is the aggregation of solute molecules into small clusters 
with packing motifs that closely resemble the spatial organization of molecules in the 
resulting crystal.
10
 Altering nucleation through the use of templates is believed to 
influence the crystal form obtained during crystallization. Tailor-made additives have 
been used to increase or decrease the likelihood of nucleating a specific form.
11
 More 
importantly, two-dimensional templates bearing functional groups complementary to the 
exposed functionality of a particular crystal face of growing nuclei have been shown to 
alter the outcome of crystal growth.
12
 The interaction between the designer surface and 
the crystal face serves to stabilize the interacting nucleus, a process known as epitaxy.
13
 
By stabilizing the nuclei of one polymorph, and not the others, one can increase the 
likelihood of controlling polymorphism. 
 
Typically, self-assembled monolayers (SAMs) are used as templates in these 
experiments. SAMs can be fabricated on coinage metals, hydroxylated substrates, and at 
air-solution interfaces.
14
 Depending on the type of monolayer system used, the molecules 
may be arranged differently or not at all. For example, thiol molecules chemisorbed on 
Au surfaces exhibit domains of two-dimensional periodicity similar to the order found in 
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crystals. Silane monolayers fabricated on hydroxylated surfaces, however, do not exhibit 
any long range order. These differences and similarities increase the number of 
conditions that can be used in experiments. Accordingly, researchers have used SAMs of 
thiols/Au, silanes/OH, and single crystal substrates (including crystals of other 
polymorphs) to selectively nucleate a desired polymorph. Other approaches include the 
use of polymeric heteronuclei,
15
 laser induced nucleation,
16
 ultra-high pressure 
crystallization,
17
 and nanoscale confinement.
18 
 
1.6 Rationale for Current Work 
Ideally, prior knowledge of the orientation and hydrogen bonding motifs of a polymorph 
is necessary to design an appropriate nucleation template; however, this is not the case 
when screening for new polymorphs. In our experiments, we chose to screen for 
polymorphs of APIs using SAMs on Au and glass substrates bearing different terminal 
functional groups. We performed recrystallizations of APIs in the presence of these 
templates with the hope of selectively nucleating a particular form. Our APIs were 
chosen based on a few simple stipulations. We wanted drug compounds that are 
polymorphic, easily characterized, and in some cases exhibit a propensity to form 
hydrates and solvates. We also wanted a diverse set of templates that would allow us to 
test a number of variables related to the composition of the substrate. Of particular 
interest were substrates that exhibit long-range order, hydrophilicity or hydrophobicity, 
and complementary functionalities. 
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2 SELECTIVE NUCLEATION - THEOPHYLLINE 
 
2.1 Background 
Theophylline, a purine derivative isolated from tea leaves, is a widely used 
bronchodilator.
19
 The compound is known to exist in four possible modifications.
20
 Of 
these four modifications, two forms occur frequently under standard pressure and 
temperature: (i) an anhydrous modification – Form II; orthorhombic (Pna21) and (ii) a 
monohydrate; monoclinic (P21/n). These two forms are known to crystallize 
concomitantly from ethanol at 70% relative humidity.
21
 The other two forms are 
extremely rare and are only encountered at very high temperatures, conditions which are 
not explored in this work. 
 
In this work we sought to investigate the effect of hydrophilic and hydrophobic substrates 
on the crystal growth of theophylline. We surmised that hydrophilic functionalities may 
interact with specific faces of particular polymorphs of theophylline. The hydrophobic 
interfaces were not expected to play a role except as controls.  
 
We initiated our work by recrystallizing theophylline from saturated ethanolic solutions 
in the presence of hydrophobic and hydrophilic surfaces. Surfaces were comprised of 
alkanethiol molecules self assembled on Au substrates. Ideally, we wanted to selectively 
nucleate one of the metastable forms of theophylline on a hydrophilic monolayer. 
Surprisingly, we reproducibly obtained the stable anhydrous form on hydrophilic 
substrates and the monohydrate on hydrophobic substrates. This unexpected result is due 
to favorable interactions between crystal faces of the anhydrous orthorhombic form and 
functional groups belonging to the monolayer. The results are also discussed in the 
context of a disparity in the number of hydrogen-bond donors and acceptors in the 
packing motif of orthorhombic theophylline. 
 
 
 
Figure 3. (a) Molecular structure of theophylline and morphologies of the (b) 
anhydrous form and (c) monohydrate calculated using BFDH theory. Symmetry 
independent faces are labeled.  
 
 
7 
2.2 Results 
Hydrophobic substrates were derived from 1-dodecanethiol (1) and 1-hexadecanethiol 
(2), hydrophilic substrates were made from 11-mercaptoundecanol (3), 11-
mercaptoundecanoic acid (4), and 16-mercaptoundecanoic acid (5). Crystallizations were 
performed at 20° C and ambient humidity (summers in Worcester can be quite humid) in 
20mL scintillation vials using a slow evaporation procedure (an aluminum foil with small 
holes regulates the rate of evaporation). All experiments were repeated five times to 
ensure reproducibility of results. 
 
 
 
Figure 4. Schematic structures of SAMs used as templates in this work. 
 
 
We observed that hydrophilic SAMs 3-5, surfaces bearing hydrogen bond donors and 
acceptors, selectively nucleated the anhydrous modification of theophylline. The walls of 
the vials contained the monohydrate indicating that both forms nucleated under the 
conditions used in this study. The exclusive growth of the anhydrous form on the SAM 
surface reveals a potential complementary interaction at the interface of the monolayer 
and the growing anhydrous crystal.  
 
Vials containing hydrophobic substrates 1 and 2 exhibited exclusive growth of the 
monohydrate. In these experiments, monohydrate crystals were also present on the vial 
walls, consistent with our previous observations of crystal growth in the presence of 
SAMs 3-5. Theophylline, when recrystallized in the absence of a template, resulted in 
concomitant growth of both modifications with the monohydrate being the predominant 
form. Crystal growth using bare Au as a template yielded similar results in accordance 
with the hydrophobic character of bare Au. Optical micrographs illustrate the effect of 
designer interfaces on the crystal growth of theophylline (Figure 5). 
 
 
 
Figure 5. Optical micrographs showing (a) the selective growth of the anhydrous 
form of theophylline on carboxy-terminated SAM-4, and (b) the growth of the 
monohydrate on methyl-terminated SAM-2. 
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The results obtained in this study can be rationalized in terms of a disparity in the number 
of hydrogen bond donors and acceptors in the anhydrous form. Theophylline has two 
acidic hydrogen bond donors (the imidazole NH and =CH groups) and three acceptors 
(the two coordinate imidazole nitrogen atom and the two carbonyl oxygen atoms). If we 
consider that each carbonyl atom can act as a bis-hydrogen bond acceptor, there is a 
shortage in the number of hydrogen bond donors. The hydrogen bond acceptors that are 
not involved in a hydrogen bond become likely candidates for template growth. 
 
Figure 6 shows the molecular arrangement at various planes corresponding to the 
macroscopic growth faces of the anhydrous form. These images show a corrugated 
packing at (110), (111), and (011) planes; thus, a greater degree of surface reconstruction 
is necessary before the corresponding crystal faces can interact with the SAM surfaces. 
Three other factors, (i) parallel alignment of molecules with respect to the planes, (ii) lack 
of distinctly exposed hydrogen bond acceptors at the interface, and (iii) relatively smaller 
size of the corresponding macroscopic faces (Figure 3), make these faces less likely to be 
nucleated by the hydrogen bonding SAMs 3-5. 
 
 
 
Figure 6. Molecular arrangement at various planes in the crystal structure of the 
anhydrous (left) and monohydrate forms (right) of theophylline. 
 
 
In contrast, the {200} and {201} faces are large (Figure 3) and the molecules lie nearly 
perpendicular to the corresponding crystal planes (Figures 6 and 7). Both sets of faces 
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expose the third hydrogen bond acceptor at the interface and hence both faces can 
potentially be nucleated by the SAMs 3-5. 
 
 
 
Figure 7. The crystal structure of the anhydrous form of theophylline. (a) The 
hydrogen bonds around a single molecule; the red and blue arrows indicate two 
distinct hydrogen bonds. (b) A molecular bilayer parallel to the bc plane; C gray, 
H yellow, N blue, O red; the green dotted lines indicate hydrogen bonds. Note the 
exposed non-hydrogen bonded carbonyl groups at the (200) plane. 
 
 
We theorized that hydrophilic functional groups present at the solution-SAM interface 
could interact with the exposed third acceptors present on the {200} faces of growing 
crystallites (Figure 7). These interactions serve to stabilize the growing nuclei by 
reducing the possibility of dissolution and enhancing the growth rate of this less stable 
modification. Powder X-ray diffraction (PXRD) analysis corroborates this theory by 
showing an increase in the intensity of the (200) reflections relative to other reflections 
when crystals were grown in the presence of SAMs 3-5.  
 
 
 
 
Figure 8. Top: Calculated PXRD diffraction patterns
22
 of the anhydrous (left) and 
monohydrate (right) forms of theophylline. Bottom: experimental PXRD patterns 
of the two forms on SAMs 5 (left) and 2 (right). Note the differences in the 
relative intensities of various peaks, particularly those labeled, in the calculated 
and experimental patterns of the anhydrous form. 
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Noting the apparent face selectivity between the {200} faces and hydrophilic SAMs 3-5, 
we sought to evaluate if the two dimensional periodicity of the substrate was involved in 
the observed results. To assess the role of the substrate geometry we conducted a set of 
crystallization trials using glass slides bearing hydroxyl functional groups under similar 
conditions observed with the SAM trials. In these experiments, we observed concomitant 
growth of the anhydrous and monohydrate modifications with the anhydrous form being 
the predominate form obtained. These experiments suggest an epitaxial interaction 
between the anhydrous form and SAMs 3-5.  
 
We used EpiCalc,
23
 a lattice matching program, to examine the geometric 
complementarity between hydrophilic monolayers and the crystal faces. All surfaces used 
in this study possess the same two dimensional periodicity (a1 = a2 = 4.97 Å and α = 
120°). The software generates an overlayer lattice (b1, b2, β) comprised of the crystal face 
being examined, and rotates this layer over the substrate lattice through a series of 
azimuthal angles (EpiCalc theory and calculations are described in section 2.5.4). During 
overlayer rotation, a dimensionless potential is calculated (V/Vo) that indicates the type 
and level of epitaxy between the two lattices. Our analysis indicates that the {200}, 
{201}, {111} and {011} faces of the anhydrous form exhibit ideal coincident epitaxy 
with the SAM surfaces and that the {200} face has the smallest supercell area 
demonstrating the best epitaxial relationship of all the faces examined (Table 1). 
 
Table 1. Parameters for geometric epitaxy. 
polymorph face 
basic cella  supercellb 
 (°) V/Vo 
b1 (Å) b2 (Å)  (°) 
 multi-
pliersc 
area 
(Å2) 
anhydrous {200} 3.830 8.501 90  4  1 130.2 24.20 0.50 
 {110} 8.501 24.908 90  1  1 211.7 30.25 0.52 
 {201} 3.830 29.914 90  2  4 916.6 34.18 0.50 
 {111} 9.324 24.908 93.62  2  4 1854.2 53.10 0.50 
 {011} 9.324 24.612 90  4  3 2753.8 58.07 0.50 
          
monohydrate {101} 14.423 15.355 90  1  1 221.5 58.20 0.55 
 {011} 4.468 20.197 95  1  3 269.7 45.75 0.50 
 {110} 13.121 15.992 92.17  1  2 419.4 20.10 0.52 
 {020} 4.468 13.121 97.79  4  2 464.7 46.75 0.54 
 {10 1 } 13.275 15.355 90  3  3 1834.5 49.15 0.50 
 {11 1 } 20.197 22.794 95.95  3  4 5494.7 54.70 0.48 
 
 
Inspection of the monohydrate faces with EpiCalc yielded only two instances of ideal 
coincident epitaxy, {011} and {10 }, other faces deviate from the ideal value of V/Vo = 
0.50. 
 
As mentioned earlier, the water molecules present in the monohydrate provide the 
necessary hydrogen bond donors to complement the idle acceptors (Figure 9). That is, 
there are no exposed hydrogen bond donors or acceptors present in the monohydrate that 
are easily accessible making the likelihood of nucleating the monohydrate on SAMs 3-5 
remote.  
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Figure 9. The crystal structure of the monohydrate form of theophylline. (a) The 
hydrogen bonds around a single molecule; the red, yellow and blue arrows 
indicate three distinct hydrogen bonds. Note that all potential donors and 
acceptors participate in hydrogen bonding. (b) The corrugated packing of the 
molecules; C gray, H yellow, N blue, O red; the green dotted lines indicate 
hydrogen bonds. Note the absence of exposed acceptors at the (101) interface. 
One of the hydrogen atoms of the water molecule is disordered. 
 
 
Interestingly, when crystallization took place in the presence of hydrophobic SAMs 1 and 
2 the monohydrate was obtained almost exclusively, suggesting a possible epitaxial 
match between growth faces and the surfaces. Investigation of the lattice registry using 
EpiCalc suggested a possible epitaxial match between the {101} faces and SAMs 1 and 
2. Noting this possibility, we investigated the orientation of theophylline molecules in the 
(101) plane of the monohydrate (Figure 9). The molecules pack in a corrugated fashion 
exposing =CH and CH3 groups, these groups may interact favorably with SAMs 1 and 2 
due to the mutual hydrophobicity of the surfaces and the functionalities exposed at the 
crystal faces. Powder X-ray diffraction analyses did not yield any instances of face 
selective growth of the monohydrate on any of the surfaces. 
 
2.3 Preparation of SAMs 
Gold coated glass slides purchased from Evaporated Metal Films had two layers of metal 
coating: a 50 Å thick chromium adhesive layer and a 1000 Å thick gold layer. The slides 
had a thickness of 1 mm; they were cut into 25 mm  37.5 mm pieces and immersed in a 
freshly prepared piranha solution (70% conc. H2SO4 and 30% aqueous H2O2) at 90°C. 
After 10 minutes the slides were taken out, rinsed with deionized water and ethanol, and 
dried with a stream of nitrogen (caution: piranha solution reacts violently with organic 
compounds and should not be stored in closed containers; it should be used only in fume 
hoods). The SAMs 1-5 (Figure 4) were fabricated by immersing these cleaned gold 
slides in 1 mM ethanolic solutions of the ω-functionalized thiols. After 8-16 h the 
substrates were taken from the solution and rinsed with copious amounts of ethanol and 
blown dry with a stream of nitrogen. Freshly prepared SAM substrates were used in the 
characterization and crystal growth experiments. 
(101)
O b
ca
b)a)
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2.4 Characterization of SAMs  
A thorough characterization of the surfaces was performed to check the extent of 
coverage, hydrophobicity and hydrophilicity of surfaces, the relative thickness of SAMs, 
and the identity of the monolayer components. 
 
2.4.1 Contact Angles were measured at nine different positions for each type of 
surface (three separate slides) with a manual goniometer (Rame-Hart, Model 100-00). 
The values reported in Table 1 were averages of these measurements. Deionized water 
droplets (5 μL) were added to each surface using a calibrated Epindorf pipette and the 
angles obtained had a maximum error of ± 1.6. The contact angles provided a rough 
measure of hydrophobicity and hydrophilicity of the surfaces. 
 
Table 2. Contact angle and ellipsometric data for SAMs 1-5. 
 
SAM Thiol 
Contact 
Angle 
Thickness (Å) 
1 dodecanethiol 96.2 ± 1.6 14.2 ± 1.2  
2 hexadecanethiol 98.4 ± 0.6 22.0 ± 1.0  
3 11-mercaptoundecanol 33.5 ± 1.2 14.6 ± 1.1  
4 11-mercaptoundecanoic acid 29.6 ± 0.8 18.3 ± 1.3  
5 16-mercaptohexadecanoic acid 28.4 ± 0.6 21.8 ± 1.2  
- bare gold 76.0 ± 0.9 - 
 
 
2.4.2 Ellipsometry measurements were performed on a manual photoelectric 
ellipsometer (Rudoph Instruments, Model 439L633P). Thickness data reported in Table 2 
were estimated assuming a refractive index of 1.462 and an extinction coefficient of 0 for 
all the substrates. The data were taken as averages of nine different spots on three 
separate slides for each type of surface. The measurements used a He-Ne laser (λ = 6328 
Å) that fell at a 70 angle on the substrate and reflected into the analyzer. 
 
2.4.3 Infrared Spectra of SAMs were collected with a Nexus FT-IR spectrometer 
(Model 670) equipped with a liquid nitrogen cooled MCTA detector and a 
ThermoNicolet grazing incidence accessory. Nitrogen gas was used to purge the optical 
path before and during data acquisition. For each sample 64 scans with a 4 cm
-1
 
resolution were collected using an IR laser incident at an angle of 75. Increasing the 
number of scans up to 480 did not significantly change the intensity of peaks. Figure 10 
shows IR spectra of SAMs in the fingerprint region. A freshly prepared gold substrate 
was used as background prior to the acquisition of each IR spectrum. These spectra 
clearly show the identity of the SAMs formed on gold substrates. The bending/wagging 
vibrations of methylene groups were seen in all the spectra. In SAM-3, CO stretching 
was seen at 1180 cm
-1
; in SAMs 4 and 5 C=O stretching appeared at 1710 and 1712 cm
-1
 
respectively. 
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Figure 10. Grazing angle IR spectra of SAMs 1-5. The plots used wave numbers 
on the x-axes and % reflectance on the y axes.  
 
 
 
2.4.4 Cyclic Voltammetry experiments were carried out using a 
potentiostat/galvanostat (EG&G Princeton Applied Research Model 273). A three-
electrode setup, wherein the SAM/gold substrate clamped with an alligator clip acted as 
the working electrode, and SCE and Pt wire acted as reference and counter electrodes, 
was used in these measurements. A 1 mM solution of K3[Fe(CN)6] was used as the redox 
active material with 50 mM KCl as the supporting electrolyte. Both solutions were 
freshly prepared and bubbled with nitrogen gas for 15 min. The complete electrochemical 
cell was placed in a Faraday cage to minimize noise. The CV curves were obtained in the 
range -0.5 to +0.7 V with a scan rate 50 mVs
-1
 and a 1 mV scan increment (Figure 11). 
When bare gold was used as a substrate the CV measurement showed the redox activity 
Fe
3+
/Fe
2+
 couple; for SAM coated gold substrates the measurements showed near zero 
activity indicating that the gold slides were fully covered with the SAMs. 
 
 
 (cm-1)
SAM-1
1800 1600 1400 1200 1000
SAM-2
SAM-3
SAM-4
SAM-5
 
14 
 
 
Figure 11. Redox activity of Fe
3+
/Fe
2+
 couple in cyclic voltammetry when bare 
gold and SAM substrates acted as working electrodes.  
 
 
2.5 Crystal Growth on SAMs 
In a 100 mL beaker, nearly saturated theophylline solution was made in ethanol (200 
proof, Pharmco) and heated at 60 C for 30 minutes. The solution was cooled to 20 C 
and transferred to 20 mL glass vials containing SAMs. Gold coated slides exposing 
SAMs were leaned at 50-90 angles against the walls of the vials. The solution was added 
until the slides were completely immersed and the vials were covered with a punctured 
aluminum foil to allow slow evaporation. All the crystal growth experiments were 
performed in parallel and at least five times at 20 C and ~70% relative humidity. The 
results in all these experiments were qualitatively similar. Crystals of monohydrate and 
anhydrous form appeared about the same time, typically between 24-36 h.  
 
One concern with crystallization by evaporation is that a metastable polymorph (in this 
case the anhydrous form) formed in the beginning may not be able to transform to a 
stable form (in this case the monohydrate) if all the solvent is evaporated. Use of 
alternative crystal growth methods (such as cooling or anti-solvent addition) may 
promote any possible phase transitions. We performed the crystal growth experiments (by 
slow evaporation of the solvent) on hydrophobic and hydrophilic SAMs in parallel using 
the same crystallization solution. These experiments are carried out multiple times to 
check for consistency. If the crystal growth method (and not the SAMs) is responsible for 
the selective growth, we should have observed such selectivity irrespective of the type of 
SAM substrate used. The reproducibility of our results (hydrogen bonding SAMs – 
anhydrous form; hydrophobic SAMs – monohydrate) shows that it is the nature of the 
SAMs (and not the growth method) that is responsible for the observed selectivity. 
 
Once the crystals appeared on SAMs, the substrates were slowly withdrawn from the vial 
and gently blown with nitrogen gas to detach any physisorbed crystals and particles. The 
crystals that were still attached to the substrate were carefully dislodged and immediately 
used in the characterization experiments. We observed that crystals were more tightly 
adhered to SAMs 3-5 than SAMs 1-2. This observation again indicates a higher degree of 
interfacial interactions in the case of hydrophilic SAMs. Crystals of monohydrate grew 
on hydrophobic SAMs 1-2 as well as on the surfaces of the vial containing these SAMs. 
In the case of hydrophilic SAMs 3-5, crystals of anhydrous form appeared on the SAM 
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surfaces whereas crystals of anhydrous and monohydrate form were grown on the vial 
surfaces. In the absence of SAMs (with or without bare gold substrates immersed in 
solution) concomitant crystallization of both forms took place; monohydrate was the 
predominant form. We used bare gold substrates as controls in all the experiments. 
Typically, very few crystals were formed on these substrates. More than 95% of these 
crystals belong to the monohydrate form. This is in accordance with the hydrophobicity 
of bare gold substrates. 
 
We also performed the crystal growth experiments of theophylline in 0.01-10 μm 
solutions of thiols 1-5. The objective of this exercise was to determine if thiol molecules 
dissolved in solution had the same effect as the SAMs 1-5 on a surface. Powder X-ray 
diffraction analysis showed that these experiments resulted in a concomitant mixture of 
anhydrous (~15-20%) and monohydrate (80-85%) forms. Similar results were obtained in 
the absence of thiol molecules dissolved in solution.  
 
2.5.1 Infrared Spectra of Polymorphs were collected with a Perkin Elmer FT-IR 
spectrometer (Model: Spectrum One) fitted with an ATR accessory. We used IR as the 
first characterization tool because the ATR accessory allowed rapid data acquisition (< 1 
min) with a small amount of sample (< 5 mg). The two polymorphs under consideration 
can be clearly identified from the spectra (Figure 12); the most distinguishable peak 
corresponds to the broad OH stretching frequency of water in the monohydrate at 3450 
cm
-1
. 
 
 
 
Figure 12. IR spectra of monohydrate and anhydrous forms of theophylline 
grown on SAMs. 
 
 
2.5.2 Differential Scanning Calorimetry measurements were carried out with 
DSC-2920 (TA Instruments) in hermetically sealed and crimped aluminum pans. 
Samples were subjected to heating in the range 30-300 °C at a rate of 10 °C per minute 
(Figure 13). The monohydrate showed a distinct endotherm near 70 °C corresponding to 
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the loss of water; the anhydrous form showed no such endotherm. Both forms displayed 
no further phase transitions until the melting endotherm, which appeared at 272 °C. 
Thermal gravimetric analysis (TGA-2950, TA Instruments) of the monohydrate showed 
that the endotherm at 70 °C in DSC corresponds to complete loss of water. 
 
 
Figure 13. Thermal analysis of monohydrate and anhydrous forms of 
theophylline. Notice the complete dehydration at 70 C in the monohydrate.  
 
 
2.5.3 Powder X-Ray Diffraction data were collected on a Rigaku Geigerflex D-
MAX/A diffractometer using Cu-Kα radiation. The instrument was equipped with a 
vertical goniometer and a scintillation counter as a detector and applied Bragg-Brentano 
geometry for data collection. X-rays were generated at a power setting of 35 kV and 35 
mA. Crystals of the anhydrous form grown on SAMs were usually small (50-100 μm); 
these were used for diffraction directly. If the crystals were larger (as in the case of 
monohydrate) they were pulverized using a mortar and a pestle prior to diffraction 
analysis. We also subjected the smaller crystals of monohydrate to diffraction without 
grinding; there was no significant change in the relative intensities of the diffraction 
peaks. Samples were transferred to a glass sample holder that had loading dimensions 1.6 
cm  2 cm and exposed to X-rays over the 2θ range 5-50° in 0.05° steps and at a scan rate 
of 2° per minute. 
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Figure 14. Schematic representation of coincident epitaxy. Substrate lattice (a1, 
a2, α) is drawn in blue; overlayer lattice (b1, b2, β) is drawn in red. Note that the 
vertices of a 3  3 supercell of the overlayer lattice reside on corners of the 
substrate lattice. 
 
 
2.5.4 Geometric Epitaxy was determined by the lattice matching program EpiCalc. 
Complete description of the program and its various applications can be found in the 
elegant original papers published by Ward and coworkers.
23
 A brief overview is provided 
here to guide the reader to understand the results presented in Table 1. EpiCalc 
determines the lattice registry by rotating an overlayer  lattice (b1, b2, β) on  a  substrate  
lattice (a1, a2, α) through a series of azimuthal angles (θ) (Figure 14). For each azimuthal 
angle, the program calculates a dimensionless potential V/Vo, whose value depends on the 
type of epitaxy between the two lattices (Table 3).  
 
Table 3. Dependence of value of V/Vo on the type of epitaxy. 
 
V/Vo Epitaxy Symmetry of Substrate Lattice  
1 incommensurate any 
0.5 coincident any 
0 commensurate non-hexagonal 
-0.5 commensurate hexagonal 
 
 
Commensurate epitaxy, an ideal form of epitaxy, involves the matching of every lattice 
point of the overlayer with the substrate lattice points. Coincident epitaxy, less ideal but 
more common form of epitaxy, involves the matching of some lattice points of the 
overlayer with substrate lattice points. One way to look at coincident epitaxy is that a 
supercell (an integral multiple of basic unit cell; e.g., 3 x 3 supercell in Figure 14) of 
overlayer exhibits commensurate epitaxy with the substrate. It follows then that the 
smaller the size of the supercell greater is the epitaxial match between two lattices. If the 
two lattices do not exhibit commensurate or coincident epitaxy, they are said to be 
incommensurate.  
a1
a2
b1
b2
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2.6 Summary  
We showed that hydrogen bonding SAMs act as templates for the selective growth of the 
thermodynamically less stable anhydrous form of theophylline. We believe that several 
properties inherent to the anhydrous form, (i) an imbalance in the number of hydrogen 
bond donors and acceptors, (ii) layered arrangement of molecules exposing the excess 
acceptors at the largest growing face, and (iii) serendipitous coincident epitaxy, led to this 
selectivity. 
 
Selective growth of polymorphs from solution is still an empirical process that requires 
lengthy and time consuming efforts. We hope this approach, and approaches by other 
groups, will help to elucidate the factors that contribute to epitaxy and selective crystal 
growth using designer templates. We also note that this approach, and others like it, are 
challenged by nucleation at sites other than the desired template. These adventitious 
templates, whether they are dust particles or scratches in the surface of the crystallization 
vessel, need to be minimized in order to increase the selectivity of a designer template. 
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3 SUPPRESSED NUCLEATION - INDOMETHACIN 
 
3.1 Background 
There have been reports in the literature of polymorphs that were once grown with ease 
and then suddenly, without significant alterations in procedure, could no longer be 
obtained. These ‘disappearing polymorphs’ as they are called, are replaced by new forms 
that are thermodynamically more stable and once nucleated, grow at the expense of the 
‘disappearing forms’.24 This process, known as Ostwald ripening,25 was responsible for 
the late stage phase transformation of Norvir® (described in Section 1.4) that resulted in 
deleterious consequences for Abbott Laboratories. Issues like the one with Norvir, have 
prompted the FDA to require rigorous polymorph screening for all new drugs to prevent 
this situation from happening again. However, without the proper screening approaches, 
one may never isolate the most stable polymorph of a given drug. 
 
A common strategy to avoid late stage phase transformations is to screen for new 
polymorphs, especially the more stable modifications, early in the formulation stage of 
drug discovery. In our earlier work (Section 2), we noted the impact of adventitious 
templates in the nucleation of different polymorphs. Bearing this point in mind, we 
fabricated surfaces bearing perfluoroalkyl functional groups (PF) that are not known to 
form favorable contacts with any other functional groups except other fluorinated 
functionalities. We chose to use silane monolayers on hydroxylated surfaces because this 
type of surfactant/substrate system would allow us to fabricate monolayers inside the 
entire crystallization vessel. 
 
Indomethacin, a non steroidal anti-inflammatory drug (NSAID), crystallizes 
concomitantly from ethanol in two modifications – α and γ.26 The stable of the two 
modifications, the γ form, was obtained exclusively on surfaces bearing the PF 
functionality. We demonstrate that the observed results are due to the suppressed 
nucleation of the metastable α form. We also show that fabricating these surfaces on the 
entire crystallization surface (monolayer covers entire interior of vial, test tube, etc.) 
results in improved polymorphic selectivity. 
 
3.2 Results 
Two methods, using nine different surfaces, were employed to investigate the effects of 
templates on the crystal growth of indomethacin. In method 1, we deposited the 
monolayer on to plasma-oxidized glass slides. The glass slides were tilted at 0°and 50° 
angles with respect to the bottom of the vial inside vials containing nearly saturated 
ethanolic solutions of indomethacin. Method 2 consisted of fabricating monolayers 
inside walls of the crystallization vessels, followed by crystal growth under the same 
conditions outlined in method 1. The two methods are depicted schematically in Figure 
15. Silane monolayers differ from thiol SAMs in a number of respects, the most striking 
difference is that silane surfaces lack long range order. That is, the surface does not 
exhibit any two dimensional periodicity that may lead to geometric epitaxy. 
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Figure 15. (a) Molecular structure of indomethacin. (b,c) Schematic depictions of 
the two methods used in this work. Light blue shading corresponds to monolayer 
coverage; dashed lines denote air solution interface.  
 
 
Silane monolayers are ideal candidates for this work because each surfactant molecule 
forms covalent bonds with the substrate that can be deposited onto any hydroxyl-bearing 
surface – particularly glass substrates.27 In addition to the functionalities listed in Figure 
16, we also used bare glass (1) and plasma-oxidized glass (2) as control surfaces.  
 
 
 
 
Figure 16. Representation of siloxane network on a glass substrate (left). 
Network formed after the reaction of various trichlorosilanes used in this work 
(right) with hydroxylated glass substrates in the presence of trace amounts of 
moisture. 
 
Using method 1 we observed that surfaces 1-8 yielded mixtures of both forms on the 
substrates with considerable polycrystalline growth along the vial walls. Surface 9 
however, yielded a singular morphology on the surface of the monolayers with the same 
polycrystalline growth present on the vial walls observed previously during trials with 
surfaces 1-8. PXRD and ATR-IR spectroscopy studies revealed that the singular 
morphology (plates) formed on substrate 9 was the γ polymorph. The polycrystalline film 
present on the vial walls was primarily the α modification. Optical micrographs 
summarizing these results are displayed in Figure 17. 
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Figure 17. Indomethacin crystal growth by using method 1. Slides functionalized 
with silane monolayers are on the left side of the images. The right portions of the 
images show the bottoms of the vials not covered by the slides. (a,b) Crystal 
growth on 5 monolayers with focus on the slide (in a) and on the vial (in b). 
Notice the predominate growth of α polymorph on both locations. (c,d) Crystal 
growth on 9 monolayers with focus on the slide (c) and on the vial (d). Notice the 
predominate growth of γ polymorph on the slide and α polymorph at the bottom 
of the vial. 
 
 
As can be seen from Figures 17 and 18, the two modifications can be distinguished 
visually based on the morphology present (α-needles; γ-plates). By separating the γ 
crystals from the total solid material we were able to determine the relative quantity of 
each polymorph present on the slides and surfaces.  
 
While this procedure lacks 100% accuracy, it avoids the possibility of inducing a phase 
transformation during grinding. Co-grinding is necessary during phase quantification by 
PXRD, ATR-IR spectroscopy and differential scanning calorimetry (DSC). Over the 
course of eight trials, we were able to generate a plot (Figure 19) examining the relative 
quantity of γ present for a given surface. 
 
The analysis of the total solid material illustrates the predominance of γ on substrate 9 
(Figure 19; ▲ and ■). If we limit our analysis to the quantity of γ present on the slide 
only (■) the selectivity is clearly more pronounced. Noting the apparent selectivity of 9, 
and the predominance of α modification on the vial surfaces, we examined the selectivity 
of surfaces 1-9 using method 2.  
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Figure 18. Calculated (top; using BFDH theory) and observed (bottom) 
morphologies of the α (left) and γ (right) polymorphs of indomethacin. 
 
 
 
 
 
Figure 19. Relative amount of γ polymorph grown on substrates 1-9 by using 
method 1 (▲: slides plus vials; ■: slides only) and method 2 (●). The position of 
the marker indicates the mean over eight experiments; error bars illustrate the 
largest and smallest quantities of the γ form obtained. Note the exclusive growth 
(no error bars) of the γ polymorph on substrate 9. 
 
 
 
By functionalizing the entire surface of the crystallization vessel (vial) we hoped to 
minimize the effects of competing templates. Surfaces 1-8 produced concomitant 
mixtures of both polymorphs in varying proportions depending on the surface in question 
(Figure 19; ●). Perfluorinated surface 9, however, yielded phase pure γ indomethacin. 
These results emphasize two points, (i) monolayer 9 selectively nucleates the more stable 
form of indomethacin and (ii) by eliminating adventitious templates we increased the 
selectivity.  
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Figure 20. Indomethacin crystal growth using method 2. (a-b) View 
perpendicular to the bottom of the vial showing the crystal growth on 5 (in a) and 
9 (in b) monolayers. In this zoomed out view only α crystals are seen in a. At a 
closer view, this vial contains ~10 % of γ crystals. Notice the exclusive growth 
(and larger size) of γ crystals in b. (c-d) View parallel to the bottom of the vial 
showing the crystals grown on 5 (left vial) and 9 (right vial) monolayers in 
ethanol (c) and acetonitrile (d) solutions. Notice the rampant crystal growth of the 
α form on the walls of 5 vials. In contrast, crystal growth is completely inhibited 
on the walls of 9 vials. Notice the plate-like γ crystals at the bottom of 9 vials. 
Arrows and boxed areas indicate areas that contain concomitant crystallization. 
 
 
Noting the marked increase in selectivity using method 2, we surmised that by 
eliminating competing nucleation sites, and choosing a surface that lacks hydrogen bond 
acceptors and donors (non-stick surface 9) we increase the likelihood of nucleating the 
stable modification. Ostwald’s rule of stages suggests that less stable forms will nucleate 
first; however, if stable modifications nucleate, they will grow at the expense of the 
metastable nuclei, explaining the selectivity in Figure 19. 
 
We altered crystallization conditions such as solvent, evaporation rate and temperature, to 
examine the ability of method 2 (with substrate 9) to nucleate the γ polymorph. Figure 
20 (d) illustrates the similarity of the results obtained using either ethanol or acetonitrile 
as a solvent. Crystallization at slower evaporation rates and lower temperatures (0° C) 
resulted in qualitatively similar outcomes, albeit an induction time of four days (slow 
evaporation) and 10 days (0° C), to those reported in Figure 20. It is also important to 
note that the α modification grew on the sides of vials 1-8 under both sets of conditions. 
These results confirm two important findings, (i) α nuclei that form in vials 1-8 do not 
convert to the stable form because they are stabilized by sites on vials 1-8 and (ii) α 
nuclei that form in vial 9 are not stabilized and facilitate the formation and growth of the 
stable form.  
 
We performed crystal growth experiments in larger vials with smaller S/V ratios (Figure 
25). Seven of the eight crystallization experiments in 3 dram vials (S/V = 2.83 cm
-1
) 
functionalized with 9 monolayers gave only the g-polymorph. In one experiment, -
dc
a b
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polymorph (6%) crystallized along with the g-form. When 20 mL vials (S/V = 2.37 cm-1) 
functionalized with 9 monolayers were used, crystals of -polymorph appeared (4-13%) 
in six of the eight experiments. Two crystal growth experiments done in 100 mL beakers 
(S/V = 1.21 cm
-1
) functionalized with 9 monolayers yielded -polymorph (18% and 
24%) along with the g-polymorph in both the experiments. Thus, the current method is 
effective when vials with high S/V ratios are used for crystal growth. Our work shows 
that researchers aiming to crystallize stable polymorphs will have higher chances of 
success at their attempts if they use narrow tubular vessels (with high values of S/V 
ratios) functionalized with 9 or other related perfluoroalkyl monolayers. 
3.3 Preparation of Substrates 
 
3.3.1 Materials (2-Carbomethoxy)ethyltrichlorosilane (3) was purchased from 
Oakwood Products Inc. and used as received. (3-Cyanopropyl)trichlorosilane (4) and 
(1H,1H,2H,2H-perfluorooctyl)trichlorosilane (9) were purchased from Aldrich and used 
without further purification. (3-Chloropropyl)trichlorosilane (5), (4-
chloromethyl)phenyltrichlorosilane (6), and indomethacin were purchased from Alfa 
Aesar and used without further purification. 10-Undecenyltrichlorosilane (7) was 
purchased from Gelest Inc. and used as received. n-Octadecyltrichlorosilane (8) was 
purchased from TCI America and used as received. Absolute ethanol and HPLC grade 
toluene were purchased from Pharmco and used as received. Precleaned 25  75  1 mm 
and 50  75  1 mm glass microscope slides were purchased from VWR and ½ dram 
(1.85 mL), 3 dram (11.09 mL) and 20 mL precleaned glass vials were purchased from 
Kimble and Wheaton Scientific and used as received. The vials were sold in these 
different denominations (dram and mL); in the following sections we refer to the vials 
using the naming given above.  
 
3.3.2 Preparation of Substrates and Plasma Oxidation Glass microscope 
slide substrates were prepared by cutting the slides into 1  10  15 mm strips. These 
strips and glass vials (to be used as silane substrates) were oxidized for approximately 
two minutes under an oxygen plasma using a plasma etcher (SPI Plasma Prep II) that was 
operating at 13.56 MHz under a 200 micron vacuum. Plasma oxidation of glass substrates 
is a well established process; it creates surfaces exposing silanol groups (Figure 21). 
After the completion of plasma oxidation, the mild vacuum inside the plasma chamber 
was maintained (to avoid contamination from outside moisture) until the glass slides and 
vials were ready for monolayer deposition. All the substrates (slides and vials) were 
oxidized immediately prior to monolayer deposition. 
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Figure 21. Schematic representation of plasma oxidation of glass substrates and 
silanization with trichlorosilane derivatives.  
3.3.3 Fabrication of Silane Monolayers on Glass Slide Substrates 
Trichlorosilane (R-SiCl3) solutions (~1 mM) were freshly prepared in toluene and 
transferred to 20 mL glass vials. Freshly oxidized glass slide strips were removed from 
the plasma etcher and immersed in the trichlorosilane solutions. The glass vials were 
completely filled with the silane solutions; they were capped and stored in a cabinet for 
approximately three hours. The slides were removed from the trichlorosilane solutions, 
rinsed thoroughly with toluene, and sonicated for 20 minutes in acetone using a Branson 
2510 sonicator. After the sonication, the slides were washed with absolute ethanol at least 
three times and dried under a stream of nitrogen. These slides exposing the silane 
monolayers at the surface (Figure 21) were used for crystal growth within 30 minutes of 
the fabrication of the monolayers. 
 
3.3.4. Fabrication of Silane Monolayers on the Inner Surfaces of Glass 
Vials Freshly prepared ~1 mM toluene solutions of trichlorosilanes were transferred to 
oxidized ½ dram glass vials that had just been removed from the plasma chamber. The 
vials were filled completely with silane solutions, capped, and stored in a cabinet. After 
three hours, the trichlorosilane solutions were pipetted out of the vials using glass Pasteur 
pipettes. The vials were rinsed thoroughly with toluene, sonicated for 20 minutes in 
acetone using a Branson 2510 sonicator, washed at least three times with absolute ethanol 
and dried under a stream of nitrogen. These vials now contained silane monolayers on 
their inner surfaces (Figure 21); they were used for crystal growth experiments within 30 
minutes of the fabrication of the monolayers. 
 
3.4 Characterization of Substrates 
 
3.4.1. Contact Angle Measurements Contact angles were measured at nine 
different positions for each type of surface (three separate slides) with a manual 
goniometer (Rame-Hart, Model 100-00). The values reported in Table 3 were averages of 
these measurements. Deionized water droplets (3 μL) were added to each surface using a 
calibrated Epindorf pipette and the angles obtained had a maximum error of ± 2.3. The 
contact angles show that the surface is modified; they provide a rough measure of 
hydrophobicity and hydrophilicity of the surfaces. 
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Table 3. Contact angle data for substrates 1-9. 
Substrate Silane 
Contact 
Angle 
1 bare glass 19.3 ± 2.3 
2 plasma treated glass 13.5 ± 2.1 
3 (2-carbomethoxy)ethyltrichlorosilane 42.1 ± 1.8 
4 (3-cyanopropyl)trichlorosilane 56.3 ± 2.2 
5 (3-chloropropyl)trichlorosilane 68.4 ± 1.8 
6 (4-chloromethyl)phenyltrichlorosilane 75.8 ± 1.4 
7 10-undecenyltrichlorosilane 86.7 ± 1.8 
8 n-octadecyltrichlorosilane 91.3 ± 1.2 
9 (1H,1H,2H,2H-perfluorooctyl)trichlorosilane 104.4 ± 1.1 
 
 
 
 
3.5 Crystal Growth  
 
3.5.1. Crystal Growth on Glass Slides Bearing Silane Monolayers In a 100 
mL beaker, 25 mM indomethacin solution was made in ethanol and heated at 60 C for 
30 minutes. Ethanol was added in excess at the beginning; the volume of the solution was 
reduced to required concentration by the evaporation of solvent during heating. The 
solution was cooled to 20 C and filtered to 20 mL glass vials containing glass slides 
bearing silane monolayers. The slides were placed at the bottom of the vial as shown in 
Figure 15 (b). Each vial was filled with 5 mL of the solution and covered with a 
perforated aluminum foil to allow the evaporation of the solvent. All the crystal growth 
experiments were performed at 20 C in parallel for at least eight times. Crystals of -
polymorph appeared on the vial walls within 10-20 hours in all the cases.  
 
3.5.2. Crystal Growth in Glass Vials Functionalized with Silane 
Monolayers on the Inner Surfaces Indomethacin solutions (25 mM) were 
prepared as above and filtered to ½ dram glass vials functionalized with silane 
monolayers. Each vial was filled with 1.2 mL of the solution and covered with a 
perforated aluminum foil to allow the slow evaporation of the solvent. All the crystal 
growth experiments were performed at 20 C in parallel for at least eight times. The 
results in all these experiments were qualitatively similar; see Figure 19 and below for 
the quantification of the results. Crystals of -polymorph appeared on the walls of vials 
1-8 within 14-20 hours in all the cases. In 9 vials, crystals of g-polymorph appeared at the 
bottom of the vials in 30-56 hours. In these vials crystal growth did not occur on the vial 
walls. Commercial indomethacin contained predominantly (> 97 %) g-polymorph. We 
also carried out crystallizations in 9 vials using indomethacin solutions that were 
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prepared from > 99% -polymorph. In three out of three experiments under these 
conditions, we observed the exclusive crystal growth of g-polymorph in 9 vials. 
 
3.5.3. Crystal Growth in Functionalized Glass Vials from Acetonitrile 
Solutions The procedure is as above except that acetonitrile is used as a solvent instead 
of ethanol. The concentrations of the solutions were 25 mM. As in the case of ethanol 
solutions, control vials 1-2 and vials functionalized with monolayers 3-8 yielded a 
mixture of - and g-polymorphs, whereas the vials functionalized with 9 monolayers 
produced only the g-polymorph. We carried out these experiments two times. 
 
3.5.4. Crystal Growth by Slower Evaporation in Functionalized Glass 
Vials We did two repeats of these experiments using 25 mM ethanol solutions in 
functionalized ½ dram vials. We sealed the vials with parafilm and made a pinhole in the 
parafilm with the tip of a needle. The objective here was to retard the rate of evaporation 
of ethanol and contrast these results with the experiments above. As above, crystals of -
polymorph grew on the walls of vials 1-8 and no crystal growth occurred on the walls of 
9 vials. The difference in this case is that -crystals appeared on the walls of vials 1-8 
after at least four days. In 9 vials, g-crystals appeared at the bottom after five to six days. 
 
 
3.6 Polymorph Characterization 
 
Figure 22. DSC Plots of α- (red, above) and γ-polymorphs (blue, below) showing 
the melting endotherms. Note that the γ-polymorph melts (158° C) at a slightly 
higher temperature than the α-form (153° C). 
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3.6.1. Differential Scanning Calorimetry These measurements were carried out 
with DSC-2920 (TA Instruments) in hermetically sealed and crimped aluminum pans. 
Samples were subjected to heating in the range 30-250 °C at a rate of 10 °C per minute 
(Figure 22). The two polymorphs showed distinct endotherms corresponding to their 
melting;  at 153 °C and g at 158 °C. These melting points are 2-3° less than the reported 
values in the literature. No other phase transitions were observed in the temperature range 
used. 
 
3.6.2. Infrared Spectra of Polymorphs Infrared spectra were collected with a 
Nexus FT-IR spectrometer (Model 670) equipped with a liquid nitrogen cooled MCTA 
detector and an ATR accessory. We used IR as the first characterization tool because the 
ATR accessory allowed rapid data acquisition (< 1 min) with a small amount of sample 
(< 5 mg). The two polymorphs under consideration can be clearly identified from the IR 
spectra (Figure 23). The -polymorph crystallizes in a noncentrosymmetric space group 
(P21) with three molecules in the asymmetric unit, whereas the g-polymorph belongs to a 
centrosymmetric space group (P 1 ) with one molecule in the asymmetric unit. 
Consequently the -polymorph has greater number IR absorptions than the g-polymorph. 
A comparison of the two spectra reveals that there are several peaks that distinguish the 
two polymorphs; the arrows in Figure 23 indicate the characteristic absorptions used by 
other researchers to identify the -polymorph.  
 
Figure 23. ATR-FT IR Spectra of α- (red, above) and γ-polymorphs (blue, 
below). Notice the significant differences between the two IR spectra; arrows in 
the top spectrum show characteristic peaks of α-polymorph. 
 
3.6.3. Powder X-Ray Diffraction Analysis Powder X-ray data were collected on 
a Rigaku Geigerflex D-MAX/A diffractometer using Cu-K radiation. The instrument 
was equipped with a vertical goniometer and a scintillation counter as a detector and 
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applied Bragg-Brentano geometry for data collection. X-rays were generated at a power 
setting of 35 kV and 35 mA. Crystals of the -polymorph were fluffy and small 
quantities of this polymorph occupied large volumes; the diffraction peaks of this 
polymorph were usually weaker than the g-polymorph. The crystals obtained from the 
experiments above were pulverized using a mortar and a pestle prior to diffraction 
analysis. Finely ground powders were transferred to a glass sample holder that had 
loading dimensions 1.6 cm  2 cm and exposed to X-rays over the 2 range 5-40° in 
0.05° steps and at a scan rate of 2° per minute. Figure 24 shows the experimental powder 
patterns along with powder patterns calculated from the single crystal X-ray structures. 
These X-ray patterns show that the crystals obtained from 9 vials correspond to the g-
polymorph. 
 
Figure 24. Calculated (top) and experimental (bottom) powder X-ray diffraction 
patterns of α- (left) and γ-polymorphs (right). The experimental diffraction pattern 
for the γ-polymorph is taken from the crystals grown in a 9 vial. The experimental 
diffraction pattern for the α-polymorph is taken from fibrous material collected 
from a 5 vial. These patterns match well with the diffraction patterns calculated 
from the single crystal structures. 
3.6.4. Quantitative Analysis of - and g-polymorphs The crystals of - and 
g-polymorphs have distinct morphologies (see Figure 18); we could readily distinguish 
between the two forms by visual inspection. We separated the crystals of g-polymorph 
grown on glass slides and vials with the aid of a pair of tweezers, a surgical blade and 
microscope. We scraped the solid material from the vial on to a glass slide (50  75 mm), 
spread the crystals, and moved the g-crystals to a different slide. These separated samples 
were then weighed on an analytical balance and the weights so obtained were used to 
calculate the relative amounts of the two polymorphs (Figure 19). Separation of this kind 
invariably left a small portion of -form in the pile of g-form and vice versa. This method 
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is thus approximate and cannot be used for accurate quantitative analysis. The main result 
of the current study (exclusive growth of the crystals of g-polymorph on 9 monolayers), 
however, is unaffected by the inaccuracies of this method. As noted in the Results, co-
grinding of samples is a prerequisite for the quantification by PXRD and IR 
spectroscopy; such co-grinding can lead to phase transition between the polymorphs or 
transition to the amorphous form. 
 
3.6.5. Effect of Surface Area-to-Volume (S/V) Ratio of the Vial on the 
Crystal Growth We performed all the experiments described (crystallizations in 
functionalized vials) using ½ dram vials. Owing to their small sizes, these vials have a 
high S/V ratio (5.61 cm
-1
); crystallization in these vials is governed predominantly by 
heterogeneous nucleation on the surfaces (as opposed to the bulk nucleation in solution).  
 
 
Figure 25. Glass vials (a: ½ dram; b: 3 dram; c: 20 mL) used for indomethacin 
crystal growth. The vials are filled with aqueous solutions of food dyes to 
accentuate the contrast between them. Most crystallizations in this work are 
performed in ½ dram vials. 
 
3.7 Summary  
The approach described in this work aims to selectively nucleate the most stable 
modifications of polymorphic compounds. Our approach is two-fold; (i) use ‘non-stick’ 
surfaces to prevent stabilization of metastable nuclei and (ii) fabricate surfaces over entire 
crystallization vessel, preferably with a high surface area to volume ratio, to eliminate 
adventitious templates and competing nucleation sites. Indeed, we were able to 
consistently obtain the more stable γ form of indomethacin utilizing this approach. 
 
a b c
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This method is facile and does not require pre-requisite knowledge of specific interfacial 
interactions necessary for template design using other approaches. We believe this 
approach will aid in polymorph screening of APIs and help to eliminate situations similar 
to the one encountered by Abbott Laboratories. 
 
We will extend this work to other APIs as well as inorganic compounds to test its 
generality and wider applicability. Preliminary results suggest that this method is also 
applicable to organic compounds with heteroatom-containing functional groups. 
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4 MICROWAVE ASSISTED POLYMORPH SELECTION 
4.1 Background 
Microwaves are routinely used to assist in chemical processes such as organic synthesis, 
hydrothermal and solvothermal syntheses, and formation of monodisperse crystallites.
28
 
The major advantages of microwave heating are increases in reaction rates, improved 
yields, energy savings, and reduced use of volatile solvents. These advantages are due to 
‘thermal effects’ associated with microwave heating mechanisms. The two integral 
characteristics of microwave heating that give rise to ‘thermal effects’ are (i) localized 
super-heating and (ii) volumetric heating. Localized super-heating refers to regions in a 
matrix that become much hotter than the bulk of the matrix when exposed to microwave 
irradiation. Volumetric heating describes the ‘inside-out’ nature of microwave heating, 
where the entire matrix heats up rapidly. Convectional heating must heat from the outside 
inwards.
29 
 
Little research has focused on the impact of microwave heating on the crystallization of 
polymorphic organic compounds. Recent work in our group has yielded instances of 
selective polymorph growth during microwave assisted crystallization. Our work will 
examine the underlying causes of the observed polymorphic selectivity and will test the 
applicability of this method to a number of organic compounds with primary focus on 
APIs. 
 
4.2 Initial Results 
We used a domestic microwave oven to heat saturated ethanol solutions of 
acetaminophen and drive these solutions to supersaturation (solutions were microwaved 
until the resulting solutions were viscous, duration of irradiation depended on initial 
saturation level and volume). Following an induction period of approximately 8-15 
minutes we observed rapid growth of the metastable form of acetaminophen. This 
experiment was repeated ten times with same results. 
 
We also repeated these experiments using a hot plate to verify if characteristics solely 
associated with microwave heating were responsible for the results. In these experiments 
we placed vials containing ethanolic solutions of acetaminophen onto a digitally 
controlled hot plate operating at 70° C and evaporated the solvent until the solutions were 
viscous. The vials were removed and a range of induction times followed (1-9 minutes) 
that yielded inconsistent results. Of the ten trials, only two runs produced phase pure 
metastable acetaminophen. The remaining eight trials produced either the stable 
modification or mixtures of the two forms. These preliminary results are promising but 
further investigations into the origin of the selectivity are required. 
 
4.3 API Crystallization 
We believe that localized super-heating caused by microwave irradiation helps to destroy 
any pre-existing nuclei in solution. Nuclei are small aggregates or clusters of molecules 
in solution that may develop and grow into crystals. By destroying all nuclei it is feasible 
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that we could add small crystals of a particular polymorph, a process known as seeding, 
and template the growth of that particular form. 
 
 
 
 
Figure 26. A schematic diagram of seeding and the mechanism by which it 
operates. (left) A seed has been added to a saturated solution. Note that the seed 
crystal is quite large in this diagram, this is not representative of the actual size of 
a seed crystal. Seed crystals are typically much smaller than this – approximately 
40 μm in each dimension. (right) The magnified view depicts a face of the seed 
crystal acting as a template to promote the growth of that particular face. Green 
molecules represent molecules that are part of the seed crystal lattice.  
 
 
Typically, seeding processes compete with the growth of existing nuclei or nuclei that 
form in solution. We surmise that microwaving saturated solutions of APIs causes two 
events to take place simultaneously, (i) dissolution of all nuclei and (ii) attainment of 
high levels of supersaturation. Evolution of a system that is highly supersaturated and 
lacks the presence of any nuclei is an ideal system to seed. We hope that this method 
enhances the success of seeding operations with respect to polymorph selectivity and 
yield.  
 
4.4 Selective Heating and Micro-Emulsions 
Microwaves exhibit the unique characteristic of selective heating.
29
 That is, one or more 
components in a mixture may be microwave susceptible (or heat up during irradiation) 
while the remaining components are microwave transparent (unaffected by microwave 
irradiation). We would like to create micro-emulsions comprised of microwave 
susceptible droplets inside a microwave transparent matrix. The droplets would be 
solutions of an API and will be driven to supersaturation as the solvent heats up and 
evaporates. A potential example would be dissolving acetaminophen in ethanol and 
creating an emulsion with mineral oil. The emulsion could then be irradiated with 
microwaves thereby heating the ethanolic droplets and increasing the saturation level of 
acetaminophen until crystallization occurs. We theorize that by encapsulating the API 
solution in a chosen media and selectively heating that component, we can eliminate 
adventitious templates and alter the crystallization environment by working with different 
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microwave transparent media. By controlling the size and size distribution of the droplets 
we may also be able to control the resulting morphology and narrow the size distribution 
of crystallites. 
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